Enhanced expression of Fas-associated proteins in decidual and trophoblastic tissues in pregnancy-induced hypertension

American Journal of Reproductive Immunology

Volumn 44, Issue 6, 2000, Pages 347-349

  Koenig, Joyce M ^a,c   Chegini, Nasser ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c NONE   (United States)

Author keywords

Decidua; Fas; Fas ligand; Placenta; Pregnancy induced hypertension; Trophoblast

Indexed keywords

CASPASE; FAS ANTIGEN; FAS LIGAND; PROTEIN BAX;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; FETUS; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; MATERNAL HYPERTENSION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST;

ANTIGENS, CD95; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; DECIDUA; FAS LIGAND PROTEIN; FEMALE; HUMANS; HYPERTENSION; MEMBRANE GLYCOPROTEINS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TROPHOBLASTS;

EID: 0034531920     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.8755-8920.2000.440605.x     Document Type: Article

References (16)

1. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S: Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival. J Clin Endocrinol Metab 1996; 81:3119-3122.
2. Smith SC, Baker PN, Symonds EM: Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 1997; 177:57-65.
3. Smith SC, Baker PN, Symonds EM: Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997; 177:1395-1401.
4. DiFederico E, Genbacev O, Fisher SJ: Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999; 155:293-301.
5. Uckan D, Steele A, Cherry, Wang BY, Chamizo W, Koutsonikolis A, Gilbert-Barness E, Good RA: Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997; 3:655.
6. Jiang SP, Vacchio MS: Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J Immunol 1998; 160:3086-3090.
7. Kauma SW, Huff TF, Hayes N, Nilkaeo A: Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 1999; 84:2188-2194.
8. Redman CW: Immunological aspects of pre-eclampsia. Baillieres Clin Obstet Gynaecol 1992; 6:601-615.
9. Marinoni E, De PO, Bresadola M, Ippoliti F, Di IR: Cell-mediated immunity imbalance in pregnancy-induced hypertension. Gynecol Obstet Invest 1994; 38:236.
10. ACOG technical bulletin: Hypertension in pregnancy. Number 219 - January 1996. Int J Gynaecol Obstet 1996; 53:175-183.
11. Faber BM, Metz SA, Chegini N: Immunolocalization of eicosanoid enzymes and growth factors in human myometrium and fetoplacental tissues in failed labor inductions. Obstet Gynecol 1996; 88:174-179.
12. Runic R, Lockwood CJ, LaChapelle L, Dipasquale B, Demopoulos RI, Kumar A, Guller S: Apoptosis and Fas expression in human fetal membranes. J Clin Endocrinol Metab 1998; 83:660-666.
13. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189-1192.
14. Zhang HG, Su X, Liu D, Liu W, Yang P, Wang Z, Edwards CK, Bluethmann H, Mountz JD, Zhou T: Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J Immunol 1999; 162:1423-1430.
15. Hunt JS, Vassmer D, Ferguson TA, Miller L: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997; 158:4122-4128.
16. von Dadelszen P, Watson RW, Noorwali F, Marshall JC, Parodo J, Farine D, Lye SJ, Ritchie JW, Rotstein OD: Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999; 181:408-414.